These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 554555)

  • 41. [The rubella immunity survey of unmarried school-aged women in Taipei and feasibility study of rubella vaccination].
    Wu LC; Yen MH; Ng HT; Yuan FJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Sep; 40(3):309-16. PubMed ID: 3502849
    [No Abstract]   [Full Text] [Related]  

  • 42. [Vaccination against rubella. A comparison of intranasal and subcutaneous aadministration of the vaccination strain RA 27-3 (author's transl)].
    Petersen EE; Büche M; Doerr HW; Neumann-Haefelin C; Luthardt T; Göttsching C; Haas R
    Dtsch Med Wochenschr; 1973 Oct; 98(40):1842-7. PubMed ID: 4762037
    [No Abstract]   [Full Text] [Related]  

  • 43. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 44. [Current state of the world's experiences with vaccination against rubella].
    Nassi L; Vecchi C
    Ann Sclavo; 1975; 17(1):17-33. PubMed ID: 1230035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Importance of active and passive anti-rubella immunoprophylaxis].
    Del Piano M
    Nuovi Ann Ig Microbiol; 1979; 30(6):404-20. PubMed ID: 554136
    [No Abstract]   [Full Text] [Related]  

  • 46. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Duration of immunity against rubella after post-partum vaccination].
    Hofmann H; Hinterberger K
    Wien Med Wochenschr; 1974 Mar; 124(11):172-4. PubMed ID: 4820575
    [No Abstract]   [Full Text] [Related]  

  • 48. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rubella vaccination. An evolving problem for obstetrics and gynecology.
    Monif GR
    Obstet Gynecol; 1972 Feb; 39(2):304-7. PubMed ID: 5057800
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of low level immunity on response to live rubella virus vaccine.
    Väänänen P; Mäkelä P; Vaheri A
    Vaccine; 1986 Mar; 4(1):5-8. PubMed ID: 3962450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Studies on rubella vaccination in adult females. I: Clinical and laboratory studies on clinical reactions].
    Nakazono N
    Hokkaido Igaku Zasshi; 1984 Mar; 59(2):180-91. PubMed ID: 6745839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination.
    Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
    Hum Immunol; 2004 Dec; 65(12):1506-15. PubMed ID: 15603879
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physiological parameters of Macaca fascicularis immunized with anti-rubella vaccine with germanium-based adjuvants.
    Karal-Ogly DD; Agrba VZ; Lavrent'eva IN; Ambrosov IV; Matelo SK; Chuguev YP; Gvaramiya IA; Gvozdik TE; Mukhametzyanova EI
    Bull Exp Biol Med; 2014 May; 157(1):81-4. PubMed ID: 24909722
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possibility of reinfection after immunisation with RA27/3 live attenuated rubella virus.
    Cusi MG; Valensin PE; Cellesi C
    Arch Virol; 1993; 129(1-4):337-40. PubMed ID: 8470956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rubella prevention.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jun; 33(22):301-10, 315-8. PubMed ID: 6427574
    [No Abstract]   [Full Text] [Related]  

  • 56. [Rubella vaccines].
    Leerhoy J; von Magnus H
    Ugeskr Laeger; 1973 Mar; 135(12):637-40. PubMed ID: 4707926
    [No Abstract]   [Full Text] [Related]  

  • 57. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Epidemiologic study on the distribution of rubella antibodies in the female population of the Marches].
    Dini M; Clementi M
    Minerva Med; 1979 Oct; 70(45):3121-3. PubMed ID: 492578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Undesirable properties of rubella vaccines with special reference to their use in women of fertile age.
    Vaheri A
    Scand J Infect Dis; 1972; 6():Suppl 6:24-7. PubMed ID: 4570530
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.